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ReprogrammingWe have previously shown that pluripotent stem cells can be induced from adult somatic cells which were ex-
posed to protein extracts isolated frommouse embryonic stem cells (mESC). Interestingly, generation of induced
pluripotent stem (iPS) cells depended on the background of ES cell lines; possible by extracts from C57, but not
from E14. Proteomic analysis of two different mES cell lines (C57 and E14) shows that embryonic Ras (E-Ras) is
expressed differently in two mES cell lines; high level of E-Ras only in C57 mESC whose extracts allows iPS cells
production from somatic cells. Here, we show that E-Ras augments the efﬁciency in reprogramming of ﬁbroblast
by promoting cell proliferation. We found that over-expression of E-Ras in ﬁbroblast increased cell proliferation
whichwas caused by speciﬁc up-regulation of cyclins D and E, not A or B, leading to the acceleratedG1 to S phase
transition. To ﬁgure out the common transcription factor of cyclins D and E, we used TRANSFAC database and
selected SP1 as a candidate which was conﬁrmed as enhancer of cyclins D and E by luciferase promoter assay
using mutants. As downstream signaling pathways, E-Ras activated only c-Jun N-terminal kinases (JNK) but
not ERK or p38. Inhibition of JNK prevented E-Ras-mediated induction of pSP1, cyclins D, E, and cell proliferation.
Finally, E-Ras transduction to ﬁbroblast enhanced the efﬁciency of iPS cell generation by 4 factors (Oct4/Klf4/
Sox2/C-myc), which was prevented by JNK inhibitor. In conclusion, E-Ras stimulates JNK, enhances binding
of Sp1 on the promoter of cyclins D and E, leading to cell proliferation. E-Ras/JNK axis is a critical mechanism
to generate iPS cells by transduction of 4 factors or by treatment of mESC protein extracts.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
ES cells are pluripotent cells derived from the inner cell mass (ICM)
of the blastocyst at least an early post-implantation stage (Evans and
Kaufman 1981) and are capable of dividing and self-renewing for
extended periods (Loebel et al. 2003). These properties made ES cells
can be used for treating Alzheimer's disease, Parkinson's disease, and
other degenerative diseases (Thomson et al. 1998). However, applica-
tion of ES cells to treatment has major hurdles, such as ethical issue
and rejection problem after transplantation (Colman and Burley
2001). One solution to circumvent these problems is the generation of
pluripotent cells by reprogramming somatic cells. In 2006, Yamanaka
has generated ES cell-like cells, which are named iPS cells, fromtitute for Cell Therapy, Seoul
gu, Seoul 110-744, Republic of
. This is an open access article undermouse ﬁbroblast with four transcription factors (Oct3/4, Sox2, C-myc
and Klf4) (Takahashi and Yamanaka 2006). Nonetheless, there are still
considerations, such as cost, safety, and efﬁciency in generating iPS
cells. Therefore, to resolve these issues, new methods are investigated,
such as reducing the number of deﬁned factors (Kim et al. 2008) and
using non-viral inducers (Huangfu et al. 2008; Shi et al. 2008; Xu et al.
2008) or proteins (Cho et al. 2010; Zhou et al. 2009) or direct conver-
sions (Han et al. 2014). In our previous study, iPS cells were generated
from ﬁbroblast by treating them with mES cells protein extract (Cho
et al. 2010). Notably, only cell extracts from C57 mES cells were able
to generate iPS cells from ﬁbroblasts, but extracts from E14 mES cells
were not (Cho et al. 2010). Through proteomic analysis of two different
mES cell lines to ﬁnd the key proteins associated with reprogramming,
we noticed proteomic contrast between C57 and E14 mES cells. The
expression of E-Ras in C57 mES cells was signiﬁcantly higher than in
E14mES cells (Jin et al. 2011). Therefore,we hypothesized that E-Ras in-
ﬂuences the reprogramming efﬁciency. Knowledge about molecular
mechanisms of reprogramming will make reprogramming efﬁciency
better. Recent studies have identiﬁed signaling pathways which playthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
482 Y.-W. Kwon et al. / Stem Cell Research 15 (2015) 481–494important roles in the reprogramming, includingMAPK/ERK (Silva et al.
2008), p53-p21 (Li et al. 2009; Hong et al. 2009; Kawamura et al. 2009)
andWnt/β-catenin (Marson et al. 2008). However, the efﬁciency of iPSC
generation is still low and the underlying mechanisms are largely
unknown. E-Ras is expressed in undifferentiated mES cells, but not in
adult mouse tissues and differentiated ES cells (Takahashi et al. 2003).
Around 80–95% of E-Ras protein binds to GTP regardless of its mem-
brane localization (Takahashi et al. 2003; Zhang et al. 1993). Therefore,
E-Ras can activate such signaling pathways constitutively, not like other
Ras proteins (Yu et al. 2014). E-Ras activates phosphatidylinositol-3-OH
kinase (PI3K) and promotes cell growth, but the cell cycle was not
affected by E-Ras–PI3K pathway (Takahashi et al. 2003; Takahashi et al.
2005). In other words, there is other pathway that E-Ras affects the cell
proliferation. In the previous studies, a high proliferation rate is required
for reprogramming efﬁciency and maintenance of stem cell identity
(Ruiz et al. 2011; Xu et al. 2013). Even though E-Ras was in the top 24-
list of Yamanaka factor candidates (Takahashi and Yamanaka 2006), it
has not been well studied in the context of reprogramming.Fig. 1. Difference of E-Ras expression between C57 and E14 mES cells. Total RNA and protein w
by real-time RCR and conventional RT-PCR. Level of mRNA from E14 mES cells was normal
cells. ***p b 0.0001. (B) Protein level of E-Ras was detected by Western blot analysis and ban
**p b 0.001. (C)(D) Immunoﬂuorescence images showed that E-Ras localized at the cell memb
Scale bars = 20 μm. Abbreviations: mES cells, mouse embryonic stem cells; E-Ras, EmbryonicIn this study, we revealed the new mechanism of E-Ras to enhance
cell cycle progression and reprogramming. E-Ras activates JNK selec-
tively, which facilitates binding of pSP-1 on the promoter of cyclins D
and E genes, enhances cell cycle progression, and increases the efﬁcien-
cy of iPS cell generation from ﬁbroblast. These ﬁndings suggest the tight
association between cell proliferation and reprogramming, where E-Ras
plays an important role.
2. Materials and methods
2.1. Cell culture
C57BL/6-background mES cells (accession #SCRC-1002; ATCC) and
E14mES cells (generously provided by JeongMook Lim, Seoul National
University, Seoul, Korea) were grown on feeder layer of STO cells
(5% CO2, 37 °C). STO cells were cultured in Dulbecco's modiﬁed Eagle's
medium (DMEM; GIBCO) high glucose supplemented with 10% Fetal
Bovine Serum (FBS; GIBCO), 1% Antibiotic-Antimycotic (GIBCO) onere isolated from E14 mES cells and C57 mES cells. (A) E-Ras mRNA level was measured
ized to a value of 1. mRNA level of E-Ras was higher in C57 mES cells than in E14 mES
ds were quantiﬁed by Image J software. E-Ras protein level was higher in C57 mES cells.
rane. Higher E-Ras expression (red) was detected in C57 mES cells than in E14 mES cells.
Ras; and DAPI, 4′, 6-diamidino-2-phenylindole.
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C (10 μg/ml medium, sigma) for 2.5 h to block mitotic activity and
seeded on 0.1% gelatin-coated plate one day before subculturing
mES cells. mES cells were cultured in DMEM (GIBCO) supplemented
with 10% Fetal Bovine Serum (FBS; GIBCO), MEM NEAA (GIBCO),
1 mM 2-Mercaptoethanol (Sigma), 1% penicillin (100 IU/ml, GIBCO)
and streptomycin (50 μg/ml, GIBCO). In ES media, Leukemia Inhibitory
Factor (LIF, Chemicon) was added to mES cells media to maintain
pluripotency. mES cells were passaged every 2–4 days.
2.2. Retroviral and lentiviral infection and iPS cell generation
E-Ras expression retroviral vector (pMXs-E-Ras; addgene) or mock
vector (pMXs-GFP; addgene) was transfected into 293T cells usingFig. 2. E-Ras up-regulates cell proliferation. (A) E-Ras overexpression was conﬁrmed by RT-
expressedNIH-3T3 cells (red) in comparison to the control cells. Scale bars= 100 μm. (C) Cell g
in E-Ras over-expressed cells compared with control cells. (D) Cell proliferation rate of E-Ras o
expressed as percent of total number of cells and E-Ras over-expressed cells showed higher O.Lipofectamine 2000 (Invitrogen). The virus soup was taken a day after
transfection and used to transduce NIH-3T3 cells with polybrene.
NIH-3T3 cells, a mouse embryonic ﬁbroblast cell line, and E-Ras over-
expressed NIH-3T3 cells were cultured in Dulbecco's modiﬁed Eagle's
medium (DMEM; GIBCO) high glucose supplemented with 10% Fetal
Bovine Serum (FBS; GIBCO), 1% Antibiotic-Antimycotic (GIBCO) on
plate (5% CO2, 37 °C). FUW-based lentiviral vectors (FUW-tetO-OSKM:
Oct4/Sox2/Klf4/C-Myc and M2rtTA; addgene) were transfected into
293T cells using PEI (Polyethylenimine; Sigma). Viral medium was
harvested at 48 h following transfection and ﬁltered through 0.45-um
pore ﬁlters. For concentration, viral supernatant was ultracentrifuged
at 25,000 rpm for 1.5 h at 4 °C, and the pellets were resuspended in
appropriate transduction medium. Virus soup was used to transduce
mouse embryonic ﬁbroblast (isolated from E 13.5 Oct3/4-promoterPCR. (B) Immunostaining images showed increased proliferation activity in E-Ras over-
rowthwasmeasured by the cell count, and the results showed increase in cell proliferation
ver-expressed NIH-3T3 cells and mock were measured by WST-1 assay. The results were
D. as compared the control cells. *p b 0.005. Abbreviations: O.D., Optical density.
484 Y.-W. Kwon et al. / Stem Cell Research 15 (2015) 481–494GFP mouse embryos; MEF) with polybrene. 24 h after transduction, the
mES cellmediumwas replaced. To inhibit JNK activity,MEFswere treated
with JNK inhibitor. MEFs were seeded on MMC-treated STO feeders.
2.3. RNA preparation and PCR analyses
Total RNA were isolated from NIH-3T3 cells and E-Ras overexpressed
NIH-3T3 cells by using the RNeasy Mini Kit (Qiagen) following the
manufacturer's protocol. 500 ng of total RNA was reverse-transcribed to
cDNA using amﬁ Rivet cDNA synthesis premix (Gendepot).Fig. 3. Effect of E-Ras on cell cycle progression. (A) FACS analysis of cell cycle progression in E
starved for 48 h and forced to enter into G1 phase after treating with 10% serum media, and
expressed cell was more rapidly progressed contrast to cell cycle of control cells. Results were
in G0/G1, S and G2/M phases. All experiments were performed in triplicate to assess consistencConventional reverse transcription (RT)-PCR was performed by
using Maxime Premix (Intron) and quantitative real-time PCR was
performed by using SYBR Green master mix (ROCHE) following the
manufacturer's protocol. The primers for PCR analysis are listed in the
Supplemental Table S1.
2.4. Confocal immunoﬂuorescence
Cells were prepared on μ-Dish (ibidi) 35mmand ﬁxed using cold 4%
formaldehyde for 15 min at room temperature. After blocking for-Ras over-expressed cells and control cells. To synchronize cell cycle, each cell was serum
we measured DNA contents every 6 h. The results showed that cell cycle of E-Ras over-
representative of 3 independent experiments. (B)(C) Mean percentage of cell populations
y of response. Abbreviations: FACS, Fluorescence-activated cell sorting.
Fig. 3 (continued).
485Y.-W. Kwon et al. / Stem Cell Research 15 (2015) 481–49430 min at room temperature, the cells were incubated with primary
antibodies overnight at 4 °C and cells were incubated for 1 h at RT
with secondary antibodies. The following primary antibodies were
used for immunoﬂuorescence: goat anti-E-Ras (1:200; Santa Cruz),
mouse anti-Oct4 (1:200; Santa Cruz), mouse anti-Nanog (1:200;
Abcam), mouse anti-SSEA1 (1:200; Abcam), mouse anti-glial ﬁbrillary
acidic protein(GFAP) (1:200; Abcam), goat anti-α-fetoprotein(AFP)
(1:200; Santa Cruz) and mouse anti-α-smooth muscle actin(α-SMA)
(1:200; Santa Cruz). Secondary antibodies included Alexa Fluor 488
conjugated goat anti-mouse IgG (1:200; Invitrogen), Alexa Fluor 555-
conjugated goat anti-mouse IgG (1:200; Invitrogen) and Alexa Fluor
555-conjugated donkey anti-goat IgG (1:500; Invitrogen). Nuclei are
stained with 4′, 6′-Diamidino-2-phenylindole dihydrochloride (DAPI;
Sigma Aldrich). Confocal microscopy images were obtained using a
Zeiss LSM 710 (Carl Zeiss).
2.5. WST-1 cell proliferation assay
For theWST-1 assay, each cell was serum-starved for 24 h and seeded
into 96-well plates (5 × 103 perwell). 10 μlWST-1 [4-[3-(4-iodophenyl)-
2-(4-nitrophenyl)-2H-5-tetrazolio]-1, 3-benzene disulfonate] reagent
(Roche) was added per well for 4 h at 37 °C in 5% CO2. The 96-well plates
were analyzed optically at 450 and 650 nm.
2.6. Cell counts-based proliferation assay
The cells were plated onto 6 well at 5 × 104 cells per well. After 48 h,
cells were harvested and cell number was counted by a hemocytometerunder invertedmicroscope. Cell numberswere expressed asmean from
one representative experiment out of three.
2.7. Flow cytometry analyses
The cell cycle was analyzed by measuring the amount of propidium
iodide (PI)-labeled DNA in ethanol-ﬁxed NIH-3T3 cells and E-Ras
overexpressed NIH-3T3 cells. To synchronize cell cycle, each cells were
starved of serum for 48 h. After that, they were treated with 10%
serum media to enter ino G1 and S phase for 0, 6, 12 and 24 h. Each
cells were harvested and ﬁxed with cold 90% ethanol in FACS tubes at
4 °C for 30 min. Then, cells were stained with propidium iodide
(PI; Sigma Aldrich) containing 0.5 mg/ml RNase (Sigma Aldrich) for
30 min at room temperature. DNA content (2N-G0/G1 and 4N-G2/M)
was then measured by ﬂow cytometry analysis. Flow cytometry
was performed on a Caliber FACS machine (Becton Dickinson). The
percentages of cells in different phases of the cell cycle were analyzed
by software (CellFit™). All experiments were performed in triplicate
to assess consistency of response.
2.8. Protein preparation and Western blot analyses
Nuclear protein and cytosolic protein of each cellwere prepared using
NE-PER nuclear and cytoplasmic extraction reagents (Thermo). 25 μg of
lysed proteins was separated by dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS-PAGE) and transferred from gel onto polyvinyl
diﬂuoride (PVDF) membrane. The membrane was blocked for 1 h with
blocking solution (5% skim milk) and incubated overnight at 4 °C with
primary antibodies: anti-E-Ras (Santa Cruz; 1:2000), anti-cyclin D (cell
signaling; 1:1000), anti-cyclin E (cell signaling; 1:1000), anti-SP1
(Millipore; 1:1000), anti-pSP1 (Assay Biotech; 1:1000), anti-ERK (cell
signaling; 1:1000), anti-pERK (cell signaling; 1:1000), anti-p38 (cell
signaling; 1:1000), anti-pp38 (cell signaling; 1:1000), anti-JNK (cell
signaling; 1:1000), anti-pJNK (cell signaling; 1:1000), and anti-α tubulin
(Santa Cruz; 1:5000). Themembranewas incubated for 1 h at RTwith in-
dividual secondary antibodies: anti-goat IgG HRP (Santa Cruz; 1:10,000),
anti-rabbit IgG HRP (Santa Cruz; 1:10,000), and anti-mouse IgG HRP
(Santa Cruz; 1:10,000). Detection was done using an ECL kit (GE
healthcare).
2.9. Luciferase assay
NIH-3T3 cells and E-Ras overexpressed NIH-3T3 cells were
transfected with pGL3-cyclin D promoter luciferase reporter vector
and Renilla vector using Lipofectamine 2000 (Invitrogen). After 6 h,
the cellswere harvested forﬁreﬂy luciferase activitieswithDual Lucifer-
ase Reporter Assay Kit (Promega) according to the manufacturer's
instructions. For pGL3-cyclin E promoter activity, pGL3-cyclin E
promoter luciferase reporter vector was used instead of pGL3-cyclin D
promoter luciferase reporter vector. Luciferase reporter plasmids of
mouse cyclin D promoter and cyclin E promoterwere charitably provid-
ed by Dr. Johan Auwerx (CNRS/INSERM/University Louis Pasteur). The
Sp1 pointmutants of the pGL3-cyclin D and E promoterwere generated
using QC lightningMulti site-directedmutagenesis kit (Stratagene) and
performed according to the manufacturer's instructions. Details of PCR
primers are list in the Supplemental Table S2.
2.10. Alkaline phosphatase staining
ALP staining was performed by a standard protocol. In brief, the
reprogrammed transgenic MEFs were rinsed with PBS, ﬁxed in 100%
methanol, rinsed with PBS again and then overlaid with BCIP/NBT sub-
strate (5-Bromo-4-Chloro-3-Indolyl Phosphate/Nitro Blue Tetrazolium;
Dako), followed by incubation at room temperature for 1 h in the dark.
The plates were scanned using an ofﬁce scanner.
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The 4 factors derived iPSC and combination of 4 factors and E-Ras
derived iPSC from MEF were harvested by trypsinization and plated
on the ultra low cluster plates (Costar, corning NY 14831) and incu-
bated for ﬁve days in the medium without LIF. After incubation, ag-
gregated cells were transferred to gelatin-coated cell culture dishes
and incubated another ﬁve days. Cells were ﬁxed and incubated with
anti-glial ﬁbrillary acidic protein (GFAP; Ectoderm marker), anti-α-
fetoprotein (AFP; Endoderm marker) and anti-α-smooth muscle actin
(SMA; Mesoderm marker) along with 4′-6-diamidino-2-phenylindole
(Sigma).Fig. 4.E-Ras promotes cell cycle via up-regulation of cyclins D andE. (A)(B)(C)(D)The expression
stimulation in the serum-starved E-Ras over-expressing cells and controls. The induction of cyc
in control cells. The induction of cyclins A and B was not affected by E-Ras over-expression. *p
by Western blotting at 6, 12, and 24 h after serum stimulation in the serum-starved E-Ras ove
expressing cell than in control ones.3. Results
3.1. E-Ras is differentially expressed among mouse ES cell-lines
Previouslywehave demonstrated that iPS cells are derived successful-
ly by treating ﬁbroblast with protein extracts frommES cells of C57 strain
but not E14mES cell lines (Cho et al. 2010). The result of proteomic anal-
ysis between two mES cells shows difference in E-Ras protein level (Jin
et al. 2011). We examined the expression level of mRNA and proteins in
C57 and E14 mES cells to conﬁrm the validity of the previous proteomic
data (Fig. 1A, B and C). Real-time RT-PCR showed that the mRNA expres-
sion level of E-Ras in C57mES cellswas almost 2.5-fold higher than that inlevel of cyclins A, B,D and Ewere assayed by real-time PCR at 0, 6, 12, and 24h after serum
lins D and E mRNA expression was earlier and greater in E-Ras over-expressing cells than
b 0.005; **p b 0.001. (E) Changes in the expression of cyclins. D, E proteins were analyzed
r-expressing cells and control ones. Proteins of cyclins D and E were higher in E-Ras over-
487Y.-W. Kwon et al. / Stem Cell Research 15 (2015) 481–494E14 mES cells (Fig. 1A). The protein expression of E-Ras was 4.5-fold
higher in C57mES cells than in E14mES cells (Fig. 1B). The immunoreac-
tivity for E-Raswas also higher in C57mES cells than that in E14mES cells
(Fig. 1C and D). Taken together, the expression level of E-Ras was highly
distinguishable among well-established mouse ES cell-lines.
3.2. E-Ras over-expression promotes a cell proliferation and cell cycle
To assess the effects of E-Ras on cell proliferation, we manufactured
E-Ras over-expressed NIH-3T3 cells by infection with E-Ras retroviralFig. 5. E-Ras enhances cyclins D and E promoter activity through Sp1. (A) ThemRNA level of Sp
starved E-Ras over-expressing cells and control ones. The induction of Sp1 mRNA expression
(B) Changes in the expression of total Sp1 and phosphorylated Sp1were analyzed byWestern b
The induction of phosphorylated Sp1 as well as total Sp1 amount was greater in E-Ras ove
(C, D) Schematic presentation of pGL3 basic luciferase reporter vector and Sp1 deletion mutan
E-Ras over-expressing cells than in control ones. Deletionmutants of the Sp1 reduced promoter
protein 1, mut, mutant.vector. We conﬁrmed the high level of E-Ras expression in the trans-
duced cells (Fig. 2A). After gene transduction, E-Ras over-expressed
cells grew faster than control cells did under the same growth condition.
Cell numbers were greater in E-Ras transduced group than control cells
after sub-culturing equal numbers. During 6 days culture, E-Ras over-
expressed cells grew faster than control ones (Fig. 2B). On the sixth
day, the growth rate of E-Ras over-expressed cells was twice as fast as
that of control ones (E-Ras over-expressed cells, 16 × 105; control
cells, 8 × 105) (Fig. 2C). In the WST-1 assay, E-Ras over-expressed
cells were 30% more proliferative than control cells (Fig. 2D). These1was analyzed by real-time PCR at 0, 6, 12, and 24 h after serum stimulation in the serum-
was greater in E-Ras over-expressing cells than in control ones. *p b 0.005; **p b 0.001.
lotting at 6, 12, and 24 h after serum stimulation in E-Ras over-expressing cells and control.
r-expressing cells than in control ones. (C–F) Promoter assay of cyclins D and E genes.
ts of cyclins D or E. (E, F) The activation of cyclin D and cyclin E promoter was higher in
activity both in E-Ras over-expressing cells and control ones. Abbreviations: Sp1, speciﬁcity
Fig. 6. E-Ras increases the expression of cyclins D, and E through the activation of E-Ras–
JNK pathway promotes the cell cycle through the JNK pathway. (A) Changes in the activa-
tion ofMAPKproteins (ERK, p38, JNK)were analyzedbyWestern blot analysis at 6, 12, and
24 h after serum stimulation in the serum-starved E-Ras over-expressing cells and
controls. All three MAPK activities were stimulated by serum, while total amount
of MAPK proteins remained unchanged. Among them, induction of phosphorylated JNK
was earlier and greater in E-Ras over-expressing cells than in control ones,whereas induc-
tion of ERK and p38 activities was not enhanced by E-Ras over-expression. (B) In order to
inhibit JNK phosphorylation, both cells were treated with 50 μM SP600125 for 6 h.
(C) Western blot analysis was used to determine phospho-Sp1, cyclin D, and cyclin E
expression. As JNK phosphorylation was inhibited, the induction of phospho-Sp1, cyclin
D, and cyclins E after serum-stimulation were prevented not only in controls but also in
E-Ras overexpressing cells. Abbreviations: MAPK, mitogen-activated protein kinase;
ERK, Extracellular signal-regulated kinase; p38, P38 mitogen-activated protein kinases;
and JNK, c-Jun N-terminal kinases. (D) E-Ras overexpressing cells were incubated with
working concentrations of the Akt inhibitor, JNK inhibitor, or DMSO as control. Each cell
was treated with 10% serum media for 0, 6, 12, and 24 h after serum starvation for 48 h.
Cell cycle was arrested only by JNK inhibition but not by Akt inhibition.
488 Y.-W. Kwon et al. / Stem Cell Research 15 (2015) 481–494results veriﬁed that E-Ras promotes cell growth. To further understand
how E-Ras stimulates cell proliferation, we analyzed cell cycle through
measuring DNA contents of E-Ras over-expressed cells and control
cells by propidium iodide (PI) ﬂow cytometric assay (Fig. 3A, B and C).
To synchronize cell cycle, each cell was starved of serum for 48 h
and forced to enter into G1 and S phase by applying 10% serum media.
E-Ras over-expressed cells entered S phase between 6 and 12 h after
serum-stimulation, which was earlier than control cells. These results
indicated that constitutive over-expression of E-Ras in NIH 3T3 cells
advanced cell cycle more quickly.
3.3. E-Ras over-expression induces cyclins D and E expression through
activation of Sp1
In order to understand themechanism of E-Ras to facilitate cell cycle
progression, we investigated the change of cell cycle related genes such
as cyclins A, B, D, and E. Total RNA was isolated from E-Ras over-
expressed cells and control ones that were prepared at 0, 6, 12, and
24 h after serum stimulation. mRNA level of cyclins A or B was induced
after serum stimulation, which was not augmented by E-Ras. However,
induction of mRNA level of cyclins D or E after serum stimulation was
augmented byE-Ras over-expression (Fig. 4A, B, C andD).Westernblot-
ting result of cyclins D and E was analogous to real-time PCR result
(Fig. 4E). Cyclins D and E are rate-limiting activators of the G1-to-S
phase transition (Resnitzky et al. 1994). Therefore, rapid cell cycle by
E-Rasmight be dependent on the expression of cyclinsD andE. Toﬁgure
out the common transcription factor which can bind and activate the
promoter of cyclins D and E,we used TRANSFAC database. From this anal-
ysis, Sp1 was selected since it was the only candidate that was predicted
to be able to bind the promoter of both cyclins D and E genes. Next, we
evaluated the expression of Sp1 by E-Ras. Real-time PCR and Western
blot data demonstrated E-Ras increased not only the expression but also
phosphorylation of Sp1 (Fig. 5A and B). To demonstrate whether E-Ras
can activate the cyclins D and E promoter, we performed luciferase
assay using full promoter sequence for both genes. Wild pGL3-cyclin D
promoter vectorwas transfected into E-Ras over-expressed cells and con-
trol cells, and then luciferase activity was determined 6 h after transfec-
tion. As expected, E-Ras signiﬁcantly activated cyclins D and E promoter.
The promoter activity of cyclins D or E increased two or three times
under E-Ras overexpression (Fig. 5E and F). Furthermore, to conduct an
examination on the speciﬁc effect of Sp1 on cyclins D and E promoter,
we constructedmutant luciferase vectorwhich hadmutation in Sp1bind-
ing site on cyclins D and E promoter respectively (Fig. 5C and D). The red
letter indicates sequence replacement. The mutation of Sp1 binding sites
on cyclins D or E promoter obliterated promoter activity, which was not
recovered even by E-Ras over-expression (Fig. 5F). Overall, these results
suggest that E-Ras induced the expression and phosphorylation of Sp1.
The activated Sp1 increased the expression of cyclins D and E through
promoter activation of both genes.
3.4. The JNK signaling is stimulated by E-Ras and is associated with
phosphorylation of Sp1
To investigate the mechanism how E-Ras phosphorylates Sp1, we
examined Ras signaling pathway. PI3K and Raf arewell known as repre-
sentative downstream signaling proteins of Ras, but they are not related
with regulating cell cycle via E-Ras activation (Takahashi et al. 2005;
Moodie et al. 1993). Therefore, we paid attention to another signaling
factor MEKK, the downstream messenger of Ras-PI3K or Ras–Raf
pathway. There are ERK, p38 MAPK, and JNK in downstream of MEKK.
The induction of phospho-ERK or phospho-p38 after serum stimulation
was not affected by E-Ras overexpression (Fig. 6A). However, the induc-
tion of phospho-JNK after serum stimulation was augmented by E-Ras
overexpression. The total ERK, p38, and JNK protein level had no
difference regardless of E-Ras overexpression. These data demonstrated
that JNK could be the linkbetween E-Ras and Sp1, but not ERKor p38. Toascertain that phosphorylated JNK could activate Sp1, E-Ras over-
expressed cells and control cells were exposed to pharmacologic JNK
inhibitor SP600125 for 6 h (Fig. 6B). JNK inhibitor reduced not only
phosphorylation of Sp1 but also expression of cyclins D and E, which
was not recovered even by E-Ras overexpression (Fig. 6C). Moreover,
to substantiate whether E-Ras-JNK regulates the cell cycle, we per-
formed a FACS analysis at 0, 6, 12, and 24 h after serum stimulation
using E-Ras overexpressing cells that were pretreated with PBS, Akt
Fig. 6 (continued).
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stimulation by E-Ras was not affected by Akt inhibitor, but signiﬁcantly
retarded by JNK inhibitor (Fig. 6D). Taken together, our data indicate
that E-Ras–JNK signaling pathway phosphorylates and activates Sp1,
resulting in the expression of cyclins D and E, and cell cycle progression
or proliferation.
3.5. E-Ras–JNK pathway enhances reprogramming by stimulating the cell
cycle
Next, to investigate whether E-Ras–JNK pathway could affect
reprogramming efﬁciency, we compared the efﬁciency of 4 factors-medicated iPS cell generation between presence and absence of E-Ras.
After gene transduction, each group of cellswas exposed in thepresence
or absence of JNK inhibitor. Cells were cultured under the standard
condition formouse iPS cell induction, andmonitored daily formorpho-
logical changes (ESC-like colony formation). After 15 days of delivery of
transgenes, we observed colonies positive for alkaline phosphatase
(Fig. 7A). ES cell-speciﬁc genes including Oct4, Nanog, Rex1 and E-Ras
were expressed in both colonies from 4 factor only and from 4 factor
plus E-Ras (5 factors), while alpha smooth muscle actin was not
expressed (Fig. 7B). Interestingly, addition of E-Ras on top of 4 factors
signiﬁcantly increased the number of colonies, which was totally
blocked by JNK inhibitor (Fig. 7A and C). JNK inhibitor blocked not
490 Y.-W. Kwon et al. / Stem Cell Research 15 (2015) 481–494only efﬁciency of reprogramming but also reprogramming itself.
Thus, E-Ras is required for enhancing the efﬁciency of iPS cell gener-
ation and JNK might be a critical signaling messenger during
reprogramming.
To investigate whether 4 factors and 5 factors derived iPS cells
have the similar characteristics each other, the colonies were immu-
nostained with the pluripotency markers including Oct4, Nanog and
SSEA1. As shown in Fig. 7D and E, the stemness markers are
expressed similarly in these two different colonies. Next, to deter-
mine the differentiation potential of these iPS cells, we used the
EB-based spontaneous differentiation protocol. The iPS cells derived
Embryoid bodies (EBs) were formed after 5 days of suspension and
the EBs are attached on gelatin coated dish (Fig. 7F). After 5 days of
attached culture, these differentiated cells from two different iPS col-
onies expressed speciﬁc markers of three germ layers, includingFig. 7. E-Ras is required for efﬁcient reprogramming through the JNK pathway. (A)MEFs were t
c-myc) or ﬁve factors (E-Ras combined with 4 factors). Cells were incubated with the JNK inhi
shown. (B) Expression of ES cell-speciﬁc genes including Oct4, Nanog, Rex1, E-Ras and differen
from 4 factors plus E-Ras (5 factors) by RT-PCR. (C) The number of colonies or generation of iP
generated from 4 factors with E-Ras and without E-Ras were stained with mouse anti-Oct4
Abcam). Scale bars = 20 μm. (F) Images of EB formation (D5) (upper row) and spontaneo
(G) Immunostaining conﬁrming in vitro differentiation into all three germ layers was sho
Abcam), goat anti-α-fetoprotein (AFP) (1:200; Santa Cruz) and mouse anti-α-smooth muscle aGFAP for ectoderm, α-SMA for mesoderm and AFP for endoderm
(Fig. 7G). From these results, we determined that the pluriptency
of 5 factors (including E-Ras)-derived iPS cells were similar to
those of 4 factors-derived iPS cells.4. Discussion
In this study, we examined how E-Ras increased cell proliferation
and stimulated the cell cycle as well as how it affected the efﬁciency
of reprogramming of somatic cell. We demonstrated that E-Ras acceler-
ated the cell cycle through the JNK pathway, leading to subsequent
phosphorylation of Sp1 and increase of cyclins D and E. E-Ras improved
the efﬁciency of 4 factors-mediated iPS cell generation, which was
blocked by JNK inhibitor (highlight).ransduced with retroviruses containing four reprogramming factors (Oct4, Sox2, Klf4, and
bitor or DMSO controls. A representative image of alkaline phosphatase (AP) staining was
tiated gene (alpha smooth muscle actin) was analyzed in colonies from 4 factors only and
S cells increased by E-Ras transduction, which was blocked by JNK inhibitor. (D)(E) iPSC
(1:200; Santa Cruz), mouse anti-Nanog (1:200; Abcam) and mouse anti-SSEA1 (1:200;
us differentiation (D5 after attached) (lower row) were shown. Scale bars = 200 μm.
wn. Images were stained with mouse anti-glial ﬁbrillary acidic protein (GFAP) (1:200;
ctin (SMA) (1:200; Santa Cruz). Scale bars = 20 μm.
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In our previous studies (Cho et al. 2010; Jin et al. 2011), E-Raswas sug-
gested as a key molecule of reprogramming after proteomic analysis of
two different mESC lines. It was the only molecule showing differential
expression between twomESC lines; high in C57mES cell linewhose pro-
tein extracts could convert ﬁbroblast to iPS cells, whereas low in E14mES
cellswhose extracts could not induce reprogramming. In order to test this
hypothesis, we made E-Ras construct and overexpressed it in somatic
cells in the present study. To our expectation, E-Ras overexpression signif-
icantly enhanced the efﬁciency of 4 factors-medicated iPS cell generation
from somatic cell. When E-Ras was combined with 4 factors, it improved
the efﬁciency of iPS cell generation (Fig. 7). This result is corroborated by a
recent study reporting the enhancing role of E-Ras in reprogramming (Yu
et al. 2014). In this paper, Yu et al. demonstrated that E-Ras stimulated
reprogramming of somatic cells through Akt and Foxo1 signaling axis.
However, we found new downstream signaling pathway of E-Ras and it
was JNK among several signaling molecules. Inhibition of JNK signaling
even in thepresence of E-Ras overexpression abolished iPS cell generation
from somatic cell. This ﬁnding suggests that E-Ras is a key molecule to
enhance reprogramming through JNK pathway.4.2. Mechanism of E-Ras to regulate reprogramming: association between
proliferation and reprogramming
E-Ras is not expressed in somatic cell or even in ES cell when they
are differentiated. The most dramatic change after overexpression ofE-Ras in somatic cell was cell-cycle progression and proliferation. One
study suggested that normal proliferation of somatic cells is required
for infection of Yamanaka factors and continuous rapid proliferation
of somatic cells after viral infection is not help to induce the
reprogramming (Xu et al. 2013). However, most researchers believe
that a high proliferation rate required for establishment of human cell
reprogramming and maintenance of embryonic stem cell identity.
Because, many previous studies demonstrated that cell cycle arrest
mediated through p21, p27 and INK4 is a barrier for cell reprogramming
(Li et al. 2009;Hong et al. 2009; Ruiz et al. 2011) and the ectopic expres-
sion of CycD1, CycD2 and CycE increased reprogramming efﬁciency up
to more than 2-fold compared to control (Ruiz et al. 2011). It has been
proposed that in hES cells, lengthening of the average time spent in
the G1, G2, and M phase increased propensity to differentiate (Ruiz
et al. 2011; Lange and Calegari 2010). Collectively, fast cell cycle and
high proliferation rate may prohibit differentiation potential and in-
crease efﬁciency of somatic cell reprogramming. Since E-Ras increases
cell proliferation and fast cell cycle through lengthening S phase and
shortening G1, G2, it may inﬂuence efﬁciency of the reprogramming
process.4.3. Mechanism of E-Ras to regulate cell-cycle and cell proliferation
Other studies have noted that E-Ras affects cell proliferation, but its
precise mechanism has not been understood. In this study we dissected
themechanism how E-Ras facilities cell cycle progression and prolifera-
tion. The most dramatic change after E-Ras expression in somatic cell
Fig. 7 (continued).
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controlled by early cyclins, such as D and E. Interestingly, E-Ras did
not increase later cyclins A and B which are expressed at later part of
the cell cycle and regulate G2 to M transition (Fig. 4). This illustrates
that E-Ras facilitates cell cycle mainly at the early phase. The question
why E-Ras selectively increased cyclins D and E was solved by bioinfor-
matics. We found that promoters of both cyclins D and E gene have Sp1
binding sites and conﬁrmed that Sp1 was the common transcriptional
activator for cyclins D and E by luciferase assay. Induction of cyclins D
and E by E-Ras was obliterated by introduction of mutation at the sp1
binding sites of promoter. However, Sp1 binding element in the pro-
moter of cyclins A and B is not reported. This signiﬁes that Sp1 may
link between E-Ras and G1-S cyclins, cyclins D and E. The amounts of
phosphorylated Sp1 and total Sp1 in E-Ras over-expressed cells were
increased more rapidly and dramatically compared to those of the con-
trol cells (Fig. 5). Interestingly, amount of total and phosphorylated
form of Sp1 were decreased along with the phases of cell cycle, which
corresponds to the established research data (Grinstein et al. 2002).
Therefore, Sp1 could be a speciﬁc stimulator for regulating early
cell cycle through cyclins D and E. Previous studies hypothesized that
E-Ras activates only Akt pathway and increases cell proliferation, but
it is not related with the cell cycle (Takahashi et al. 2003; Yu et al.
2014). In the present study, we investigated the missing link between
E-Ras and Sp1 to regulate cell cycle. Since MEKK is one of major down-
stream messengers of Ras signaling pathway, we focused on MEKKfamily including ERK, p38, and JNK. JNK was the only kinase that was
activated by stimulation of E-Ras. Pharmacological inhibitor of JNK
attenuated the effects of E-Ras on cell cycle by down-regulating Sp1-
cyclin D/E axis. In contrast, Akt inhibitor did not change the cell cycle
in the present study (Fig. 6D), which was consistent with the other
study (Takahashi et al. 2003). It signiﬁed that E-Ras augments the cell
cycle progression through speciﬁc activation of JNK signaling. Thus the
mechanism how E-Ras facilitates cell cycle is the sequential activation
of JNK pathway, Sp1 transcription factor, increase of cyclins D and E,
resulting in G1-S transition.5. Conclusion
This study shows for the ﬁrst time that E-Ras activates the JNK–Sp1
signaling pathway. Activated Sp1 binds to the cyclins D and E promoter
and increases both gene and protein expression levels, resulting in
an accelerated cell cycle and cell proliferation. Furthermore, we demon-
strate that E-Ras promotes reprogramming of somatic cells by direct
activation of JNK pathway.Author contributions
No disclosure of potential conﬂicts of interest.
Fig. 7 (continued).
493Y.-W. Kwon et al. / Stem Cell Research 15 (2015) 481–494Acknowledgments
This study was supported by a grant from the Innovative Research
Institute for Cell Therapy (A062260) and supported by the a grant of
the Korea Health Technology R&D Project through the Korea Health
Industry Development Institute (KHIDI), funded by the Ministry of
Health & Welfare, Republic of Korea (grant number: HI14C1541and
HI14C1277).
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.scr.2015.09.004.
References
Evans, M.J., Kaufman, M.H., 1981. Establishment in culture of pluripotential cells from
mouse embryos. Nature 292, 154–156.Loebel, D.A., Watson, C.M., De Young, R.A., Tam, P.P., 2003. Lineage choice and differenti-
ation inmouse embryos and embryonic stem cells. Dev. Biol. 264, 1–14.
Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S.,
et al., 1998. Embryonic stem cell lines derived from human blastocysts. Science 282,
1145–1147 (New York, N.Y.).
Colman A, Burley JC. A legal and ethical tightrope. Science, ethics and legislation of stem
cell research. EMBO Rep. 2001;2:2–5.
Takahashi, K., Yamanaka, S., 2006. Induction of pluripotent stem cells from mouse
embryonic and adult ﬁbroblast cultures by deﬁned factors. Cell 126, 663–676.
Kim, J.B., Zaehres, H., Wu, G., Gentile, L., Ko, K., Sebastiano, V., et al., 2008. Pluripotent stem
cells induced from adult neural stem cells by reprogramming with two factors.
Nature 454, 646–650.
Huangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A.E., et al., 2008.
Induction of pluripotent stem cells by deﬁned factors is greatly improved by small-
molecule compounds. Nat. Biotechnol. 26, 795–797.
Shi, Y., Do, J.T., Desponts, C., Hahm, H.S., Scholer, H.R., Ding, S., 2008. A combined chemical
and genetic approach for the generation of induced pluripotent stem cells. Cell Stem
Cell 2, 525–528.
Xu, Y., Shi, Y., Ding, S., 2008. A chemical approach to stem-cell biology and regenerative
medicine. Nature 453, 338–344.
Cho, H.J., Lee, C.S., Kwon, Y.W., Paek, J.S., Lee, S.H., Hur, J., et al., 2010. Induction of
pluripotent stem cells from adult somatic cells by protein-based reprogramming
without genetic manipulation. Blood 116, 386–395.
494 Y.-W. Kwon et al. / Stem Cell Research 15 (2015) 481–494Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T, et al. Generation of induced pluripotent stem
cells using recombinant proteins. Cell Stem Cell 2009;4:381–4.
Han, J.K., Chang, S.H., Cho, H.J., Choi, S.B., Ahn, H.S., Lee, J., et al., 2014. Direct conversion of
adult skin ﬁbroblasts to endothelial cells by deﬁned factors. Circulation 130,
1168–1178.
Jin, J., Kwon, Y.W., Paek, J.S., Cho, H.J., Yu, J., Lee, J.Y., et al., 2011. Analysis of differential
proteomes of induced pluripotent stem cells by protein-based reprogramming of
ﬁbroblasts. J. Proteome Res. 10, 977–989.
Silva, J., Barrandon, O., Nichols, J., Kawaguchi, J., Theunissen, T.W., Smith, A., 2008. Promo-
tion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol. 6,
e253.
Li, H., Collado, M., Villasante, A., Strati, K., Ortega, S., Canamero, M., et al., 2009. The Ink4/
Arf locus is a barrier for iPS cell reprogramming. Nature 460, 1136–1139.
Hong, H., Takahashi, K., Ichisaka, T., Aoi, T., Kanagawa, O., Nakagawa, M., et al., 2009.
Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.
Nature 460, 1132–1135.
Kawamura, T., Suzuki, J., Wang, Y.V., Menendez, S., Morera, L.B., Raya, A., et al., 2009.
Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature
460, 1140–1144.
Marson, A., Foreman, R., Chevalier, B., Bilodeau, S., Kahn, M., Young, R.A., et al., 2008. Wnt
signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell 3,
132–135.
Takahashi, K., Mitsui, K., Yamanaka, S., 2003. Role of ERas in promoting tumour-like
properties in mouse embryonic stem cells. Nature 423, 541–545.Zhang, X.F., Settleman, J., Kyriakis, J.M., Takeuchi-Suzuki, E., Elledge, S.J., Marshall, M.S., et
al., 1993. Normal and oncogenic p21ras proteins bind to the amino-terminal
regulatory domain of c-Raf-1. Nature 364, 308–313.
Yu, Y., Liang, D., Tian, Q., Chen, X., Jiang, B., Chou, B.K., et al., 2014. Stimulation of somatic
cellreprogramming by ERas-Akt-FoxO1 signaling axis. Stem cells 32, 349–363
(Dayton, Ohio).
Takahashi, K., Nakagawa, M., Young, S.G., Yamanaka, S., 2005. Differential membrane
localization of ERas and Rheb, two Ras-related proteins involved in the phos-
phatidylinositol 3-kinase/mTOR pathway. J. Biol. Chem. 280, 32768–32774.
Ruiz, S., Panopoulos, A.D., Herrerias, A., Bissig, K.D., Lutz, M., Berggren, W.T., et al., 2011. A
high proliferation rate is required for cell reprogramming andmaintenance of human
embryonic stem cell identity. Curr. Biol.: CB. 21, 45–52.
Xu, Y., Wei, X., Wang, M., Zhang, R., Fu, Y., Xing, M., et al., 2013. Proliferation rate of
somatic cells affects reprogramming efﬁciency. J. Biol. Chem. 288, 9767–9778.
Resnitzky, D., Gossen, M., Bujard, H., Reed, S.I., 1994. Acceleration of the G1/S phase
transition by expression of cyclins D1 and E with an inducible system. Mol. Cell.
Biol. 14, 1669–1679.
Moodie, S.A., Willumsen, B.M., Weber, M.J., Wolfman, A., 1993. Complexes of Ras.GTP
with Raf-1 and mitogen-activated protein kinase kinase. Science (New York, N.Y.)
260, 1658–1661.
Lange, C., Calegari, F., 2010. Cdks and cyclins link G1 length and differentiation of
embryonic, neural and hematopoietic stem cells. Cell Cycle 9, 1893–1900.
Grinstein, E., Jundt, F., Weinert, I., Wernet, P., Royer, H.D., 2002. Sp1 as G1 cell cycle phase
speciﬁc transcription factor in epithelial cells. Oncogene 21, 1485–1492.
